These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30431525)

  • 1. Persistence of High Neutralizing Antibody Titers After Neonatal and Early Infantile Infection with Parechovirus-A3.
    Izumita R; Aizawa Y; Watanabe K; Saitoh A
    Pediatr Infect Dis J; 2019 Jul; 38(7):e159-e161. PubMed ID: 30431525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Neutralizing Antibody Titers against Parechovirus A3 in Maternal and Cord Blood Pairs and Perinatal Factors.
    Shimizu H; Hashimoto K; Sato M; Sato A; Sato M; Maeda H; Kyozuka H; Kawasaki Y; Yokoyama T; Fujimori K; Yasumura S; Hosoya M
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):320-325. PubMed ID: 31107961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States.
    Karelehto E; Brouwer L; Benschop K; Kok J; Basile K; McMullan B; Rawlinson W; Druce J; Nicholson S; Selvarangan R; Harrison C; Lankachandra K; van Eijk H; Koen G; de Jong M; Pajkrt D; Wolthers KC
    Emerg Infect Dis; 2019 Jan; 25(1):148-152. PubMed ID: 30561318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 3.
    Aizawa Y; Watanabe K; Oishi T; Hirano H; Hasegawa I; Saitoh A
    Emerg Infect Dis; 2015 Nov; 21(11):1966-72. PubMed ID: 26485714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Immune Responses in Serum and Cerebrospinal Fluid From Neonates and Infants Infected With Parechovirus-A3 or Enteroviruses.
    Habuka R; Aizawa Y; Izumita R; Domon H; Terao Y; Takihara H; Okuda S; Saitoh A
    J Infect Dis; 2020 Jul; 222(4):681-689. PubMed ID: 32201899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of parechovirus A1, A3 and A4 antibodies in Yamagata, Japan, between 1976 and 2017.
    Mizuta K; Komabayashi K; Aoki Y; Itagaki T; Ikeda T
    J Med Microbiol; 2020 Dec; 69(12):1381-1387. PubMed ID: 33170118
    [No Abstract]   [Full Text] [Related]  

  • 7. Maternal parechovirus A (PeV-A) shedding, serostatus, and the risk of central nervous system PeV-A infections in infants.
    Klatte JM; Harrison CJ; Pate B; Queen MA; Neuhart J; Jackson MA; Selvarangan R
    J Clin Virol; 2021 Sep; 142():104939. PubMed ID: 34390928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Parechovirus 1, 3 and 4 Neutralizing Antibodies in Dutch Mothers and Infants and Their Role in Protection Against Disease.
    Karelehto E; Wildenbeest JG; Benschop KSM; Koen G; Rebers S; Bouma-de Jongh S; Westerhuis BM; de Jong MD; Pajkrt D; Wolthers KC
    Pediatr Infect Dis J; 2018 Dec; 37(12):1304-1308. PubMed ID: 30382954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014.
    Tanaka S; Aoki Y; Matoba Y; Yahagi K; Itagaki T; Matsuzaki Y; Mizuta K
    Microbiol Immunol; 2016 Dec; 60(12):854-858. PubMed ID: 27925289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental outcomes of newborns and infants with parechovirus and enterovirus central nervous infection: a 5-year longitudinal study.
    van Hinsbergh T; Elbers RG; Bouman Z; van Furth M; Obihara C
    Eur J Pediatr; 2022 May; 181(5):2005-2016. PubMed ID: 35119491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood Outcomes Following Parechovirus Infections in a US Young Infant Cohort.
    Kilbride H; Jackson MA; Selvarangan R
    Pediatr Infect Dis J; 2021 Apr; 40(4):295-299. PubMed ID: 33710974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human parechovirus seroprevalence in Finland and the Netherlands.
    Westerhuis B; Kolehmainen P; Benschop K; Nurminen N; Koen G; Koskiniemi M; Simell O; Knip M; Hyöty H; Wolthers K; Tauriainen S
    J Clin Virol; 2013 Sep; 58(1):211-5. PubMed ID: 23891146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel scoring system for differentiating parechovirus-A3 and enterovirus infection in neonates and young infants.
    Izumita R; Aizawa Y; Habuka R; Watanabe K; Otsuka T; Kitamura N; Akazawa K; Saitoh A
    J Clin Virol; 2020 Mar; 124():104256. PubMed ID: 32006746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute heart failure due to dilated cardiomyopathy exacerbated by systemic parechovirus A1 infection in an infant.
    Maki S; Aizawa Y; Ito Y; Suda M; Saitoh A
    Int J Infect Dis; 2021 Mar; 104():273-275. PubMed ID: 33453393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Evolution and Epidemiology of Parechovirus-A3 in Japan, 1997-2019.
    Aizawa Y; Kasamatsu T; Nagasawa K; Watanabe K; Saitoh A
    J Infect Dis; 2023 Jan; 227(2):288-294. PubMed ID: 35608411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-associated differentiation marker is an essential host factor for human parechovirus PeV-A3 entry.
    Watanabe K; Oka T; Takagi H; Anisimov S; Yamashita SI; Katsuragi Y; Takahashi M; Higuchi M; Kanki T; Saitoh A; Fujii M
    Nat Commun; 2023 Mar; 14(1):1817. PubMed ID: 37002207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Parechovirus A4 Central Nervous System Infections among Infants in Kansas City, Missouri, USA.
    Sasidharan A; Harrison CJ; Banerjee D; Selvarangan R
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Pathogenesis and Inflammatory Responses to Experimental Parechovirus Encephalitis.
    Jan MW; Su HL; Chang TH; Tsai KJ
    Front Immunol; 2021; 12():753683. PubMed ID: 34899705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parechovirus A Infection of the Intestinal Epithelium: Differences Between Genotypes A1 and A3.
    García-Rodríguez I; van Eijk H; Koen G; Pajkrt D; Sridhar A; Wolthers KC
    Front Cell Infect Microbiol; 2021; 11():740662. PubMed ID: 34790587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parechovirus A3 (PeV-A3)-associated myalgia/myositis occurs irrespective of its genetic cluster: a longitudinal molecular epidemiology of PeV-A3 in Yamagata, Japan between 2003 and 2016.
    Mizuta K; Aoki Y; Komabayashi K; Tanaka S; Yamakawa T; Shimizu Y; Itagaki T; Katsushima F; Katsushima Y; Ikeda T
    J Med Microbiol; 2019 Mar; 68(3):424-428. PubMed ID: 30556799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.